Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users

British Journal of Pharmacology

Volumn 170, Issue 7, 2013, Pages 1410-1420

  Van Wel, J H P ^a   Kuypers, K P C ^a   Theunissen, E L ^a   Toennes, S W ^b   Spronk, D B ^c,d   Verkes, R J ^c,d   Ramaekers, J G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GOETHE UNIVERSITY   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY   (Netherlands)

Author keywords

addiction; cannabis; cocaine; cross tolerance; impulsivity; tolerance

Indexed keywords

CANNABIS; COCAINE; TETRAHYDROCANNABINOL; CENTRAL STIMULANT AGENT; DRONABINOL; PSYCHEDELIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CANNABIS ADDICTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG INTOXICATION; DRUG USE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RISK; TASK PERFORMANCE; CANNABIS SMOKING; COCAINE DEPENDENCE; COGNITION; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TIME; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRONABINOL; FEMALE; HALLUCINOGENS; HUMANS; IMPULSIVE BEHAVIOR; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TIME FACTORS; YOUNG ADULT;

EID: 84887773935     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12425     Document Type: Article

References (45)

1. Barkus E, Morrison PD, Vuletic D, Dickson JC, Ell PJ, Pilowsky LS, et al. (2011). Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study. J Psychopharmacol 25: 1462-1468.
2. Bechara A, (2005). Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 8: 1458-1463.
3. Bossong MG, Berckel BNM, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, et al. (2009). Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34: 759-766.
4. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, et al. (1997). Acute effects of cocaine on human brain activity and emotion. Neuron 19: 591-611.
5. Burns M, (1991). Pharmacology of cocaine and its relationship to behavior impairment. In The effects of drugs on human performance and behavior: drugs and driving/drugs in the workplace.
6. Burns M, (1992). Cocaine effects on performance. In International Conference on Alcohol, Drugs and Traffic Safety, pp 613-619.
7. Childers SR, Breivogel CS, (1998). Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51: 173-187.
8. Crean RD, Crane NA, Mason BJ, (2012). An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 5: 1-8.
9. EMCDDA (2009). Polydrug use: patterns and responses (Luxembourg).
10. EMCDDA (2011). Annual drug update: 2011 in review.
11. Faure A, Richard JM, Berridge KC, (2010). Desire and dread from the nucleus accumbens: cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat. PLoS ONE 5: e11223.
12. Fillmore MT, Rush CR, Hays L, (2002). Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157-167.
13. Fillmore MT, Rush CR, Hays L, (2005). Cocaine improves inhibitory control in a human model of response conflict. Exp Clin Psychopharmacol 13: 327-336.
14. Fillmore MT, Rush CR, Hays L, (2006). Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction 101: 1323-1332.
15. Garavan H, Kaufman JN, Hester R, (2008). Acute effects of cocaine on the neurobiology of cognitive control. Philos Trans R Soc Lond B Biol Sci 363: 3267-3276.
16. Gonzalez R, (2007). Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev 17: 347-361.
17. Hart CL, Ilan AB, Gevins A, Gunderson EW, Role K, Colley J, et al. (2010). Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav 96: 333-341.
18. Hazekamp A, Ruhaak R, Zuurman L, Gerven JVA, Verpoorte ROB, (2006). Evaluation of a vaporizing device (Volcano 1) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci 95: 1308-1317.
19. Jex HR, McDonnell JD, Phatak AV, (1966). A 'critical' tracking task for manual control research. IEEE 7: 138-145.
20. Kalivas PW, Volkow ND, (2005). The neural basis of addiction? A pathology of motivation and choice. Am J Psychiatry 162: 1403-1413.
21. Kauert GF, Iwersen-Bergmann S, Toennes SW, (2006). Assay of delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J Anal Toxicol 30: 274-277.
22. Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM, et al. (2013). Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One 8: e70378.
23. Logan GD, Cowan WB, (1984). On the ability to inhibit thought and action: a theory of an act of control. Psychol Rev 91: 295-327.
24. McDonald J, Schleifer L, Richards JB, Wit H, (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28: 1356-1365.
25. Messer SB, (1976). Reflection-impulsivity: a review. Psychol Bull 83: 1026-1052.
26. Metrik J, Kahler CW, Reynolds B, McGeary JE, Monti PM, Haney M, et al. (2012). Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) 223: 489-499.
27. Panlilio LV, Solinas M, Matthews S, Goldberg SR, (2007). Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32: 646-657.
28. Perales JC, Verdejo-Garcia A, Moya M, Lozano O, Perez-Garcia M, (2009). Bright and dark sides of impulsivity: performance of women with high and low trait impulsivity on neuropsychological tasks. J Clin Exp Neuropsychol 31: 927-944.
29. Perkonigg A, Lieb R, Höfler M, Schuster P, Sonntag H, Wittchen HU, (1999). Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 94: 1663-1678.
30. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, (2004). Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry 56: 86-94.
31. Ramaekers JG, Kuypers KPC, (2006). Acute effects of 3,4- methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 31: 1048-1055.
32. Ramaekers JG, Kauert G, Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR, (2006a). High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31: 2296-2303.
33. Ramaekers JG, Moeller MR, Ruitenbeek P, Theunissen EL, Schneider E, Kauert G, (2006b). Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 85: 114-122.
34. Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR, (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 23: 266-277.
35. Ramaekers JG, Theunissen EL, Brouwer M, Toennes SW, Moeller MR, Kauert G, (2011). Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) 214: 391-401.
36. Shallice T, (1982). Specific impairments of planning. Philos Trans R Soc Lond 298: 199-209.
37. Solowij N, (1998). Cannabis and Cognitive Functioning. Cambridge University Press: Cambridge.
38. Toennes SW, Steinmeyer S, Maurer H-J, Moeller MR, Kauert GF, (2005). Screening for drugs of abuse in oral fluid-correlation of analysis results with serum in forensic cases. J Anal Toxicol 29: 22-27.
39. Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF, (2008). Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 32: 470-477.
40. Toennes SW, Schneider K, Kauert GF, Wunder C, Moeller MR, Theunissen EL, et al. (2011). Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users. Anal Bioanal Chem 400: 145-152.
41. Urban NBL, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S, et al. (2012). Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry 71: 677-683.
42. Van Dyke CV, Barash P, Jatlow P, Byck R, (1976). Cocaine: plasma concentrations after intranasal application in man. Science 191: 859-861.
43. van Wel JHP, Kuypers KPC, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG, (2012). Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors. PLoS ONE 7: e40187.
44. Wilkinson P, Dyke CV, Jatlow P, Barash P, Byck R, (1980). Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27: 386-394.
45. Zanettini C, Panlilio LV, Alicki M, Goldberg SR, Haller J, Yasar S, (2011). Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci 5: 1-21.